The Role of Dickkopf Homologue 3 DKK3 in Gallbladder Carcinoma
Loading...
Date
item.page.authors
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
Gallbladder cancer (GBC) is a prevailing malignancy of the biliary tract cancers1 . The incidence of GBC has been rising rapidly in recent decades worldwide2 . The prognosis for this disease is dismal as most of the symptoms are non-specific leading to a definitive diagnosis only at a late stage. The existing information about gallbladder cancer including the genetic and molecular level alterations is limited. It is believed that GBC is consequence of accumulation of multiple genetic alterations. Multiple studies have reported mutations in oncogenes, tumor suppressor genes, DNA repair genes, microsatellite instability as well as epigenetic changes to be associated with GBC. Our inhouse published GBC RNA-Seq data indicates widespread dysregulation of molecules involved in the Wnt pathway and its downstream targets3 . Wnt and its downstream effector regulators are important for cancer progression, including tumor initiation, tumor growth, cell death and metastasis4 . Genetic and epigenetic alterations of the Wnt pathway leads to altered gene expression, which can not only serve as biomarkers but also serve as targets for therapeutic interventions in GBC. Amongst the protein affected by Wnt signaling, Dickkopf proteins (DKK1 4) are known to play a key role. Previous studies in gallbladder cancer have reported that nucleotide changes in Wnt signaling molecules like SFRP4, DKK2 and DKK3 may contribute in tumorigenesis of gallbladder cancer by changing genes expression of Wnt signaling pathway5 . The role and mechanisms of DKK3 molecule remains elusive throughout cancers. DKK3, through its interplay with the Wnt signaling pathway is involved in embryonic development6 and has the property of tumor suppression and is linked with and#946;-catenin pathways7-9 . Multiple studies have reported DKK3 as tumor suppressor gene since its decreased expression, however few studies also report it as an oncogene. The expression of DKK3 in cancers like hepatocellular carcinoma, lymphoblastic leukemia, prostate cancer, renal cell carcinoma,..